BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14705479)

  • 1. Advances in the treatment of bone metastases.
    Reich CD
    Clin J Oncol Nurs; 2003; 7(6):641-6. PubMed ID: 14705479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ
    Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurologic sequelae of bone changes in multiple myeloma and its therapy].
    Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B
    Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
    Higano CS
    Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal complications of malignancy.
    Coleman RE
    Cancer; 1997 Oct; 80(8 Suppl):1588-94. PubMed ID: 9362426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
    Hortobagyi GN; Theriault RL; Porter L; Blayney D; Lipton A; Sinoff C; Wheeler H; Simeone JF; Seaman J; Knight RD
    N Engl J Med; 1996 Dec; 335(24):1785-91. PubMed ID: 8965890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy in the management of bone pain.
    Hoskin PJ
    Clin Orthop Relat Res; 1995 Mar; (312):105-19. PubMed ID: 7543390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain.
    Paes FM; Serafini AN
    Semin Nucl Med; 2010 Mar; 40(2):89-104. PubMed ID: 20113678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastases, general and clinical issues.
    Greco C; Forte L; Erba P; Mariani G
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):337-52. PubMed ID: 21738111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Painful osseous metastases.
    Smith HS
    Pain Physician; 2011; 14(4):E373-403. PubMed ID: 21785487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiopathology and new therapeutic strategies in the management of bone metastases of prostate cancer].
    Lebret T; Méjean A; Houédé N
    Prog Urol; 2011 May; 21(5):301-7. PubMed ID: 21514531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The systemic treatment of bone metastases.
    Houston SJ; Rubens RD
    Clin Orthop Relat Res; 1995 Mar; (312):95-104. PubMed ID: 7543393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates: clinical experience.
    Coleman RE
    Oncologist; 2004; 9 Suppl 4():14-27. PubMed ID: 15459426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone metastases from advanced cancers: clinical implications and treatment options.
    Fitch M; Maxwell C; Ryan C; Löthman H; Drudge-Coates L; Costa L
    Clin J Oncol Nurs; 2009 Dec; 13(6):701-10. PubMed ID: 19948468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone metastases: Part I--Pathophysiology.
    Fisher G; Mayer DK; Struthers C
    Clin J Oncol Nurs; 1997 Apr; 1(2):29-35. PubMed ID: 9410649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach to the management of the patient with metastatic bone disease.
    Weber KL; Lewis VO; Randall RL; Lee AK; Springfield D
    Instr Course Lect; 2004; 53():663-76. PubMed ID: 15116657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history and treatment of bone complications in prostate cancer.
    Saad F; Clarke N; Colombel M
    Eur Urol; 2006 Mar; 49(3):429-40. PubMed ID: 16431012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of metastatic bone disease and risk of skeletal morbidity.
    Coleman RE
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6243s-6249s. PubMed ID: 17062708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
    Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.